Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (22)

« Back to Publications

Cardiac lymphatics retain LYVE-1-dependent macrophages during neonatal mouse heart regeneration.

Chapman BG. et al, (2025), Nat Cardiovasc Res, 4, 1258 - 1276

The anti-cancer drug trametinib suppresses angiotensin-induced cardiac remodelling in mice but is detrimental to function

Cooper STE. et al, (2025)

Role of the Lymphatics in Cardiac Disease.

Cooper STE. et al, (2024), Arterioscler Thromb Vasc Biol, 44, 1181 - 1190

Striatin plays a major role in angiotensin II-induced cardiomyocyte and cardiac hypertrophy in mice in vivo.

Cull JJ. et al, (2024), Clin Sci (Lond), 138, 573 - 597

Striatin plays a major role in angiotensin II-induced cardiomyocyte and cardiac hypertrophy in mice in vivo

Cull JJ. et al, (2023)

Erratum to 'Defining Commotio Cordis': The American Journal of Cardiology Volume 124, Issue 10, 15 November 2019, Pages 1649-1650.

Maron BJ. et al, (2023), Am J Cardiol, 193

Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice.

Alharbi HO. et al, (2022), Clin Sci (Lond), 136, 1661 - 1681

PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses.

Marshall JJT. et al, (2022), Biochem J, 479, 1467 - 1486

Of Mouse and Man: Cross-Species Characterization of Hypertensive Cardiac Remodeling.

Cooper STE. et al, (2022), Int J Mol Sci, 23

Characterisation of hypertensive heart disease: pathological insights from a sudden cardiac death cohort to inform clinical practice.

Westaby JD. et al, (2022), J Hum Hypertens, 36, 246 - 253

Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.

Clerk A. et al, (2022), Biochem J, 479, 401 - 424

RAF 'PARADOX BREAKER' PLX8394 ACTIVATES ERK1/2 VIA CRAF, WITH NO EFFECT ON ANGII-INDUCED CARDIAC REMODELLING IN MICE

Cooper S. et al, (2022), HEART, 108, A148 - A148

RAF 'Paradox Breaker' Inhibitor, PLX8394, Enhances Inflammation And Apoptosis In Murine Hypertension In Vivo

Cooper ST. et al, (2022), CIRCULATION RESEARCH, 131

The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension.

Meijles DN. et al, (2021), Clin Sci (Lond), 135, 1631 - 1647

The insulin receptor family and protein kinase B (Akt) are activated in the heart by alkaline pH and α1-adrenergic receptors.

Meijles DN. et al, (2021), Biochem J, 478, 2059 - 2079

Load More